MPS Pharmaa Limited (BOM:531686)
India
· Delayed Price · Currency is INR 1.650
0.00 (0.00%)
At close: Mar 9, 2026
MPS Pharmaa Revenue
MPS Pharmaa had revenue of 204.00 INR in the twelve months ending December 31, 2025, down -99.96% year-over-year. In the fiscal year ending March 31, 2025, MPS Pharmaa had annual revenue of 477.20K, down -49.05%.
Revenue (ttm)
204.00
Revenue Growth
-99.96%
P/S Ratio
154,577.50
Revenue / Employee
11.33
Employees
18
Market Cap
31.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 477.20K | -459.47K | -49.05% |
| Mar 31, 2024 | 936.67K | 703.67K | 302.00% |
| Mar 31, 2023 | 233.00K | -94.46K | -28.85% |
| Mar 31, 2022 | 327.46K | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fabino Enterprises | 204.36M |
| Cresanto Global | 5.91M |
| Brawn Biotech | 172.71M |
| Decipher Labs | 148.66M |
| Ganga Pharmaceuticals | 26.93M |
| Vivanza Biosciences | 1.10B |
| Unjha Formulations | 148.12M |
| Beryl Drugs | 176.65M |